• KOLs
  • Primary Cns Lymphoma

Location & Type arrow_drop_up Concepts arrow_drop_down Orgs arrow_drop_down
Filter by Concept
#1
Aya Haggiagi
Aya Haggiagi
Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York-Presbyterian Hospital, 710 W 168th St, 9th Floor, ...
Known for star star star star star
Cns Lymphoma | Nivolumab Maintenance | Rituximab Lenalidomide | Methotrexate Primary
#2
Gerald Illerhaus
Gerald Illerhaus
Department of Hematology and Oncology, University Hospital Freiburg, Freiburg, Germany;
Known for star star star star star
Refractory Primary | Cns Lymphoma | Central Nervous | Conventional Chemotherapy

#3
Joshua Lukenbill
Joshua Lukenbill
Known for star star star star star
Phase Iii | Lung Cancer | Absence Unacceptable | Arm Receive
#4
Celltrion
Celltrion
Known for star star star star star
Rheumatoid Arthritis | Evaluate Safety | Ulcerative Colitis | Subcutaneous Infliximab
#5
Won Seog Kim
Won Seog Kim
Department of Medicine, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea;
Known for star star star star star_half
Cns Lymphoma | Refractory Mantle | Lymphoid Malignancy | Cemiplimab Pd1
#6
Huiqiang Huang
Huiqiang Huang
Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. State Key Laboratory of Oncology in South China, Guangzhou, China; Collaborative ...
Known for star star star star star_half
Newly Diagnosed | Cns Lymphoma | Pegylated Interferon | Refractory Relapsed
#7
Raffles Hospital, Singapore
Raffles Hospital, Singapore
Known for star star star star star_half
Testicular Dlbcl | Primary Cns | Refractory Ebv | Subtypes Durvalumab
#8
International Extranodal Lymphoma Study Group (IEL
International Extranodal Lymphoma Study Group (IEL
Known for star star star star star_half
Marginal Zone | Subcutaneous Rituximab | Malt Lymphoma | Primary Chemotherapy
#9
Xian-Janssen Pharmaceutical Ltd.
Xian-Janssen Pharmaceutical Ltd.
Known for star star star star star_half
Paliperidone Palmitate | Myelodysplastic Syndrome | Depressive Disorder | Fed Conditions
#10
Michael Kiel
Michael Kiel
Internal Medicine Residency Program, The Wright Center for Graduate Medical Education, Scranton, PA
Known for star star star star star_half
Recurrent Primary | Cns Lymphoma | Temsirolimus Refractory | Initial Chemotherapy
#11
Melanie Binsker
Melanie Binsker
Known for star star star star star_half
Primary Cns | Lymphoma Temsirolimus | Refractory Recurrent | Initial Chemotherapy
#12
New Approaches to Brain Tumor Therapy Consortium
New Approaches to Brain Tumor Therapy Consortium
Known for star star star star star_half
Recurrent Malignant | Emd 121974 | Surgical Resection | Tumor Cells
#13
Osnat Bairey
Osnat Bairey
Known for star star star star star_border
Primary Cns | Inhibitor Ibrutinib | Tyrosine Kinase | Methotrexate Protocol
#14
Tali Siegal
Tali Siegal
The Departments of Haematology and Clinical Epidemiology, Chaim Sheba Medical Center, Tel-Hashomer, and Sackler School of Medicine, Tel-Aviv University, Israel
Known for star star star star star_border
Serum Dna | Primary Cns | Brain Cancer | Potential Application
#15
Kazuhiko Mishima
Kazuhiko Mishima
Known for star star star star star_border
Adjuvant Temozolomide | Primary Cns | Phase Iii | Brain Radiotherapy
#16
Kelly Hoye
Kelly Hoye
Sheila and David Fuente Graduate Program in Cancer Biology, University of Miami-Miller School of Medicine, Miami, Florida.
Known for star star star star star_border
Nivolumab Consolidation | Induction Chemotherapy | Cns Lymphoma | Stage Primary
#17
Christopher Dittus
Christopher Dittus
From the Department of Pathology and the Office of Cancer Prevention and Control, The George Washington University Cancer Institute, Washington, DC (Dr Henson); The George ...
Known for star star star star star_border
Nivolumab Consolidation | Induction Chemotherapy | Cns Lymphoma | Stage Primary

 

Recently Asked Questions

View all FAQs

Urea cycle disorder is a metabolic disorder that prevents the body from properly removing ammonia from the blood. Ammonia is a waste product produced by the...

 

Glycopyrrolate Glycopyrrolate is an oral and injectable medication used to treat conditions such as nausea, vomiting, stomach ulcers, and irritable bowel syndrome. It...

 

Colonoscopy A colonoscopy is a medical procedure in which a doctor or other trained medical professional inserts a long, flexible tube into the rectum and...

 

Colorectal Cancer Colorectal cancer is a type of cancer that affects the colon (the large intestine) and the rectum (the end of the colon). Symptoms of colorectal cancer can...

 

Glycoscience Glycoscience is the study of carbohydrates, including their structure, function and biosynthesis.

 

Phase I Trial Of Methotrexate, Rituximab, Lenalidomide, And Nivolumab (Nivo-Mr2)...

[ CLINICAL_TRIAL ] ... (CNS) lymphoma. Lenalidomide may stop or slow primary CNS lymphoma by blocking the growth of new blood vessels necessary for tumor growth. Immunotherapy with monoclonal antibodies, such as ...
Known for star star star star star
Cns Lymphoma | Nivolumab Maintenance | Rituximab Lenalidomide | Methotrexate Primary

Randomized Phase Ii Trial On Fitness- And Comorbidity- Tailored Treatment In...

[ CLINICAL_TRIAL ] ... system lymphomas are rare aggressive malignancies, usually treated in two steps: an induction phase (where a combination of chemotherapy is given) followed by a consolidation phase (where ...
Known for star star star star star
Diagnosed Primary | Chemotherapy Induction | Receive Brain | Cns Lymphoma

Lccc1841: A Phase 2 Trial Of Acalabrutinib In Relapsed/refractory Primary And...

[ CLINICAL_TRIAL ] ... (CNS) lymphoma. Acalabrutinib has not been approved by the Food and Drug Administration (FDA) for the treatment of CNS lymphoma. However, FDA has approved its use for treatment of another ...
Known for star star star star star_half
Cns Lymphoma | Refractory Primary | Acalabrutinib Ibrutinib | Cancer Drug

Phase 2 Study Of Temsirolimus In Refractory And Recurrent Primary Cns Lymphoma....

[ CLINICAL_TRIAL ] ... primary CNS lymphoma (PCNSL) after initial chemotherapy with a high-dose methotrexate containing regimen. 37 patients are planned to be treated with weekly infusions of 25mg Temsirolimus ...
Known for star star star star star_half
Primary Cns | Lymphoma Temsirolimus | Recurrent Refractory | Initial Chemotherapy

Phase Ii Study Of Combination Treatment Of Methotrexate, Ibrutinib, And...

[ CLINICAL_TRIAL ] ... primary CNS lymphoma. Detailed Description Primary central nervous system lymphoma (PCNSL) is a rare and aggressive extranodal Non-Hodgkin Lymphoma. Induction treatment of PCNSL in most ...
Known for star star star star star_half
Cns Lymphoma | Newly Diagnosed | Ibrutinib Combination | Methotrexate Temozolomide

A Phase 1b Trial Nivolumab Consolidation Following Completion Of High-Dose...

[ CLINICAL_TRIAL ] ... PCNSL in terms of a tolerated dose (based on dose-limiting toxicities) for the expansion phase of the study (Stage 2).The primary objective of Stage 2 is to evaluate the efficacy of ...
Known for star star star star star_half
Nivolumab Consolidation | Induction Chemotherapy | Cns Lymphoma | Stage Primary

Combination Of Rituximab And Methotrexate Followed By Rituximab And Cytarabine In...

[ CLINICAL_TRIAL ] ... primary CNS lymphoma followed by combination of rituximab and methotrexate followed by rituximab and cytarabine. Detailed Description As described, standard therapy for patients with ...
Known for star star star star star_border
Cns Lymphoma | Elderly Primary | Rituximab Cytarabine | Autologous Therapy

Phase Ii Study Of Durvalumab In Combination With Lenalidomide In...

[ CLINICAL_TRIAL ] ... PRIMARY CNS LYMPHOMA AND PRIMARY TESTICULAR DLBCLPatients with relapsed refractory subtypes of DLBCL who fulfill the inclusion / exclusion criteria will be recruited to this trial and ...
Known for star star star star star_border
Testicular Dlbcl | Primary Cns | Refractory Ebv | Subtypes Durvalumab

Optimizing Matrix As Remission Induction In Pcnsl: De-Escalated Induction...

[ CLINICAL_TRIAL ] ... primary CNS lymphoma is superior to the standard MATRix protocol in terms of event free survival. Detailed Description This phase III study investigates if a de-escalated induction ...
Known for star star star star star_border
Escalated Induction | Primary Cns | Phase Iii | Newly Diagnosed

Chemotherapy Free Treatment With Venetoclax And Obinutuzumab For Relapsed /...

[ CLINICAL_TRIAL ] ... primary CNS lymphoma. Detailed Description This is a phase IB study investigating the pharmacokinetics of the combination venetoclax and obinutuzumab in the cerebrospinal fluid of patient ...
Known for star star star star star_border
Primary Cns | Cerebrospinal Fluid | Venetoclax Obinutuzumab | Chemotherapy Free